EZH2 is increased in paediatric T-cell acute lymphoblastic leukemia and is a suitable molecular target in combination treatment approaches
about
Inhibition of EZH2 via activation of SAPK/JNK and reduction of p65 and DNMT1 as a novel mechanism in inhibition of human lung cancer cells by polyphyllin I.Long noncoding RNA XIST promotes malignancies of esophageal squamous cell carcinoma via regulation of miR-101/EZH2.Solanine induced apoptosis and increased chemosensitivity to Adriamycin in T-cell acute lymphoblastic leukemia cells.
P2860
EZH2 is increased in paediatric T-cell acute lymphoblastic leukemia and is a suitable molecular target in combination treatment approaches
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
EZH2 is increased in paediatri ...... mbination treatment approaches
@ast
EZH2 is increased in paediatri ...... mbination treatment approaches
@en
type
label
EZH2 is increased in paediatri ...... mbination treatment approaches
@ast
EZH2 is increased in paediatri ...... mbination treatment approaches
@en
prefLabel
EZH2 is increased in paediatri ...... mbination treatment approaches
@ast
EZH2 is increased in paediatri ...... mbination treatment approaches
@en
P2093
P2860
P50
P1476
EZH2 is increased in paediatri ...... mbination treatment approaches
@en
P2093
A Iannotta
G Pecoraro
M C Affinita
M Di Martino
M Ramaglia
P2860
P2888
P356
10.1186/S13046-015-0191-0
P577
2015-08-14T00:00:00Z
P5875
P6179
1013263174